Bosch J - Search Results

1

Pathophysiology and a Rational Basis of Therapy.

Gracia-Sancho J, Maeso-Díaz R, Bosch J. Gracia-Sancho J, et al. Among authors: bosch j. Dig Dis. 2015;33(4):508-14. doi: 10.1159/000374099. Epub 2015 Jul 6. Dig Dis. 2015. PMID: 26159267

2

Nitric oxide and portal hypertension.

González-Abraldes J, García-Pagán JC, Bosch J. González-Abraldes J, et al. Among authors: bosch j. Metab Brain Dis. 2002 Dec;17(4):311-24. doi: 10.1023/a:1021957818240. Metab Brain Dis. 2002. PMID: 12602508 Review.

3

Increased hepatic resistance: a new target in the pharmacologic therapy of portal hypertension.

Hernández-Guerra M, García-Pagán JC, Bosch J. Hernández-Guerra M, et al. Among authors: bosch j. J Clin Gastroenterol. 2005 Apr;39(4 Suppl 2):S131-7. doi: 10.1097/01.mcg.0000155513.17715.f7. J Clin Gastroenterol. 2005. PMID: 15758648 Review.

4

Variceal bleeding: pharmacological therapy.

Bosch J, Abraldes JG. Bosch J, et al. Dig Dis. 2005;23(1):18-29. doi: 10.1159/000084722. Dig Dis. 2005. PMID: 15920322 Free article. Review.

5

The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis.

Matei V, Rodríguez-Vilarrupla A, Deulofeu R, Colomer D, Fernández M, Bosch J, Garcia-Pagán JC. Matei V, et al. Among authors: bosch j. Hepatology. 2006 Jul;44(1):44-52. doi: 10.1002/hep.21228. Hepatology. 2006. PMID: 16799985

6

NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats.

Angermayr B, Fernandez M, Mejias M, Gracia-Sancho J, Garcia-Pagan JC, Bosch J. Angermayr B, et al. Among authors: bosch j. Gut. 2007 Apr;56(4):560-4. doi: 10.1136/gut.2005.088013. Epub 2006 Jul 19. Gut. 2007. PMID: 16854998 Free PMC article.

7

Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.

Carrión JA, Navasa M, García-Retortillo M, García-Pagan JC, Crespo G, Bruguera M, Bosch J, Forns X. Carrión JA, et al. Among authors: bosch j. Gastroenterology. 2007 May;132(5):1746-56. doi: 10.1053/j.gastro.2007.03.041. Epub 2007 Mar 24. Gastroenterology. 2007. PMID: 17484872 Clinical Trial.

8

Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.

Fernandez M, Mejias M, Garcia-Pras E, Mendez R, Garcia-Pagan JC, Bosch J. Fernandez M, et al. Among authors: bosch j. Hepatology. 2007 Oct;46(4):1208-17. doi: 10.1002/hep.21785. Hepatology. 2007. PMID: 17654489

9

Vascular deterioration in cirrhosis: the big picture.

Bosch J. Bosch J. J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S247-53. doi: 10.1097/MCG.0b013e3181572357. J Clin Gastroenterol. 2007. PMID: 17975472 Review.

10

The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats.

Mejias M, Garcia-Pras E, Tiani C, Bosch J, Fernandez M. Mejias M, et al. Among authors: bosch j. J Cell Mol Med. 2008 Sep-Oct;12(5A):1690-9. doi: 10.1111/j.1582-4934.2008.00218.x. Epub 2008 Jan 11. J Cell Mol Med. 2008. PMID: 18194463 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,948 results

Search Page